S5 GLP-1 receptor agonists and pancreatic cancer risk in drug-naive patients with type 2 diabetes

Authors

Khaled Alsabbagh Alchirazi, Advocate Health - MidwestFollow
Ahmed El Telbany
Michelle Baliss
Muaz Alsabbagh
Wissam Kiwan
Mohammad Bilal

Recommended Citation

Alchirazi K, El Telbany A, Baliss M, Alsabbagh M, Kiwan W, Bilal M. S5 GLP-1 Receptor Agonists and Pancreatic Cancer Risk in Drug-Naive Patients With Type 2 Diabetes. The American Journal of Gastroenterology. 2024; 119 (10S): S3-S4. doi: 10.14309/01.ajg.0001028388.64456.1e.

Document Type

Abstract